CVS Health Corporation
CVS
$67.01
-$0.84-1.24%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.98% | 2.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.98% | 2.19% | |||
| Cost of Revenue | -5.45% | 2.34% | |||
| Gross Profit | 14.26% | 1.13% | |||
| SG&A Expenses | 3.35% | -2.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.50% | 1.79% | |||
| Operating Income | 73.22% | 27.14% | |||
| Income Before Tax | 23.10% | 1,924.76% | |||
| Income Tax Expenses | 66.00% | 1,379.41% | |||
| Earnings from Continuing Operations | 9.80% | 2,185.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -114.29% | 31.25% | |||
| Net Income | 8.21% | 1,789.66% | |||
| EBIT | 73.22% | 27.14% | |||
| EBITDA | 45.86% | 14.74% | |||
| EPS Basic | 8.04% | 1,789.73% | |||
| Normalized Basic EPS | 64.41% | 37.90% | |||
| EPS Diluted | 7.98% | 1,789.73% | |||
| Normalized Diluted EPS | 64.29% | 37.67% | |||
| Average Basic Shares Outstanding | 0.16% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.16% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.07% | -0.95% | |||